Atlas Trials

Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant Tumors

Clinical trial NCT04060472 · UNKNOWN

Trial details

NCT number
NCT04060472
Sponsor
Dong Wang
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Advanced Hepatobiliary and Malignant Tumors
Start date
2019-08-20
Primary completion
2021-04-20
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.